Tissue-factor-pathway inhibitor 2
Trypsinogen 4 boosts tumor endothelial cells migration through proteolysis of tissue factor pathway inhibitor-2
12
Tissue factor pathway inhibitor 2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis
11
Promoter hypermethylation and silencing of tissue factor pathway inhibitor 2 in oral squamous cell carcinoma
13
Reduced expression of tissue factor pathway inhibitor-2 contributes to apoptosis and angiogenesis in cervical cancer
9
Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma
8
Pro-coagulant activity during exercise testing in patients with coronary artery disease
7
The genetic variation rs6903956 in the novel androgen-dependent tissue factor pathway inhibitor regulating protein (ADTRP) gene is not associated with levels of plasma coagulation factors in the Singaporean Chinese
6
The effects of antioxidant vitamins on the expression of tissue factor and tissue factor pathway inhibitor genes in human monocytic and endothelial cell lines
327
Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbits
12
Further insight into the heparin-releasable and glycosylphosphatidylinositol-lipid—anchored forms of tissue factor pathway inhibitor
12
The effects of tissue factor pathway inhibitor and anti-b-2-glycoprotein-I IgG on thrombin generation
7
The effects of tissue factor pathway inhibitor and anti beta 2 glycoprotein I IgG on thrombin generation
7
A preliminary estimation of tissue factor pathway inhibitor (TFPI) and protein C in patients with intracranial tumors
6
Anti tissue factor pathway inhibitor activity in patients with primary antiphospholipid syndrome
5
Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit
9
Tissue Factor and Other Hemostatic Parameters in Patients with Advanced Peripheral Artery Disease After Endovascular Revascularization – Search for Hemostatic Factors which Indicate Restenosis
6
A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI)
8
Anti-tissue factor pathway inhibitor activity in subjects with antiphospholipid syndrome is associated with increased thrombin generation
6
Original Article Correlation and prognostic significance of MMP-2 and TFPI-2 differential expression in pancreatic carcinoma
10
Anti tissue factor pathway inhibitor activity in subjects with antiphospholipid syndrome is associated with increased thrombin generation
6